You are here
The objective of the ESMO Symposium on Signalling Pathways in Cancer is to bring together basic scientists, academics, clinical researchers and industry researchers, medical and young oncologists with a special interest in the field in order to facilitate knowledge sharing through a series of interactive sessions and workshops.
The focus of the Symposium is on the preclinical and clinical issues relevant for targeting DNA damage response and the effect of systemic and radiation therapies.
We are pleased to announce that the 5th Symposium focusing on DNA damage response will be held in partnership with EACR.
ESMO Scientific Co-Chair
- Ruth Plummer, Newcastle upon Tyne, UK
EACR Scientific Co-Chair
- Eli Pikarsky, Jerusalem, Israel